---
created: 2025-04-13
updated: 2025-04-13T10:53
id: HEILDl+&bO
specialty: pharmaco
specialty_id: 338
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::05-antisense-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::05-antisense-drugs::nusinersen
  - "source/ak-step1-v11:": 
  - theme/nbme::27
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-stimulants-&-biochemistry-pharmacology::enzyme-replacement-therapy,gene-therapy,and-cystic-fibrosis-therapy
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::4-loweryield"
type: flashcard
---

# Question
Nusinersen is an antisense drug used to treat **Spinal Muscular Atrophy**

---

# Answer
- SMA eg Werdnig-Hoffman disease = loss of function in anterior horn of spinal cord == progressive system wide atrophy of skeletal muscles == early death  - Used to treat SMA associated with a mutation in SM1, nusinersen works by modulating the splicing of SMN2 pre-mRNA to mimic SMN1 mRNA (increases the length of SMN2 mRNA)